Tag: Pharmacokinetics Award

Mridul Guleria | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mridul Guleria — Guru Nanak Dev University

Mridul Guleria
Affiliation Guru Nanak Dev University
Country India
Scopus ID 59174404600
Documents 14
Citations 84
h-index 4
Subject Area Pharmacology
Event World Science Awards
ORCID 0009-0008-5898-8134

Mridul Guleria is a researcher affiliated with Guru Nanak Dev University, India, whose documented scholarly profile is associated with the field of pharmacology. The available bibliometric record identifies 14 documents, 84 citations, and an h-index of 4 in Scopus. [1] These indicators provide a concise quantitative view of the researcher’s indexed scholarly output and citation visibility.

This academic recognition profile presents the researcher’s research background, contributions, publication record, research impact, and suitability for consideration for the Best Researcher Award associated with the World Science Awards. The assessment is framed using the supplied bibliographic information and publicly identifiable researcher records rather than unsupported claims of distinction.

Abstract

Mridul Guleria is affiliated with Guru Nanak Dev University and works within the subject area of pharmacology. The researcher’s indexed profile records 14 documents, 84 citations, and an h-index of 4. [1] The profile is additionally associated with an ORCID identifier, providing a persistent scholarly identity record. [2] On the basis of the supplied academic indicators, the Best Researcher Award profile highlights scholarly productivity, citation-based visibility, subject-area relevance, and participation in research activities within pharmacology.

Keywords

Mridul Guleria; Best Researcher Award; pharmacology; pharmaceutical research; Guru Nanak Dev University; research impact; scholarly publications; citation analysis; Scopus; ORCID; World Science Awards.

Introduction

Pharmacology is a multidisciplinary area concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with living systems. Research in this field contributes to the broader development and evaluation of pharmacological knowledge and can intersect with pharmaceutical sciences, biomedical research, toxicology, and related disciplines.

Within an academic recognition framework, researcher evaluation may consider several dimensions, including research productivity, publication activity, citation performance, subject relevance, originality, scholarly contribution, and broader research influence. Bibliometric databases such as Scopus can provide quantitative indicators for assessing indexed research output, while ORCID provides a persistent identifier that helps distinguish researchers and connect scholarly works with their authors. [1] [2]

Research Profile

The supplied research profile identifies Mridul Guleria as being affiliated with Guru Nanak Dev University in India and specializing in pharmacology.

These figures should be interpreted as a snapshot of the indexed research record and may change as databases update publication and citation information. [1]

Research Contributions

Mridul Guleria’s documented research specialization is pharmacology. The available record supports recognition of research activity within this subject area, while the supplied bibliometric indicators provide evidence of an established indexed publication and citation record. [1]

For academic evaluation purposes, the contribution profile can be considered across the following dimensions:

  • Subject-area engagement: Research activity is associated with pharmacology, a field relevant to drug research and biomedical science.
  • Scholarly productivity: Fourteen documents are recorded in the supplied Scopus profile.
  • Citation visibility: The supplied profile records 84 citations, indicating that indexed publications have received measurable scholarly referencing.
  • Research continuity: The presence of multiple indexed documents provides evidence of continuing scholarly publication activity.
  • Researcher identification: The association of Scopus and ORCID identifiers supports clearer attribution of scholarly work to the researcher. [1] [2]

Publications

The supplied Scopus record indicates 14 indexed documents associated with Mridul Guleria. [1] The available input does not provide a complete publication bibliography, individual article titles, journal names, publication dates, citation distributions, or DOI identifiers. Accordingly, no specific publication titles or DOI values are attributed here without bibliographic verification.

For a complete publication assessment, the Scopus author record and the researcher’s ORCID profile can be consulted to identify publications, author associations, and persistent scholarly records. [1] [2]

Research Impact

The supplied Scopus indicators show 84 citations across 14 documents and an h-index of 4. [1] These measures provide quantitative evidence of citation activity and scholarly visibility within the indexed research literature.

Citation counts and h-index values are useful indicators but should not be interpreted independently of publication context, career stage, discipline, authorship patterns, journal characteristics, or the nature of individual contributions. A balanced assessment of research impact therefore benefits from combining bibliometric information with qualitative evaluation of research originality, methodological quality, relevance, collaboration, and contribution to the field.

The presence of an ORCID identifier further supports persistent researcher identification and can facilitate the reliable association of scholarly outputs with the appropriate researcher. [2]

Award Suitability

The Best Researcher Award profile for Mridul Guleria is supported by the supplied evidence of academic affiliation, subject-area specialization, indexed publication activity, and citation performance. The World Science Awards provides the event context for this recognition. [3]

Based on the available information, relevant evaluation dimensions include:

  • Academic relevance: The researcher’s specialization in pharmacology aligns with a recognized scientific and biomedical research domain.
  • Publication record: Fourteen Scopus-indexed documents demonstrate measurable scholarly productivity. [1]
  • Citation performance: Eighty-four citations provide an observable indicator of scholarly attention to the indexed research output. [1]
  • h-index: An h-index of 4 provides an additional quantitative measure of citation distribution across the researcher’s indexed publications. [1]
  • Researcher identity: The availability of both Scopus and ORCID identifiers supports transparent scholarly attribution. [1] [2]

Taken together, these documented indicators provide a reasonable academic basis for consideration under a Best Researcher Award framework. Final award decisions, however, should be based on the official evaluation methodology, verified publication records, research quality, originality, and other criteria established by the awarding organization. [3]

Conclusion

Mridul Guleria is an India-based researcher affiliated with Guru Nanak Dev University whose documented research area is pharmacology. The supplied scholarly profile records 14 documents, 84 citations, and an h-index of 4 in Scopus, alongside an ORCID identifier that provides a persistent researcher identity. [1] [2]

The available evidence demonstrates measurable research productivity and citation visibility and provides a documented foundation for consideration for the Best Researcher Award at the World Science Awards. [3] Any final recognition should be determined through independent verification and the formal assessment criteria of the awarding body.

References

  1. Elsevier. (n.d.). Scopus author details: Mridul Guleria, Author ID 59174404600. Scopus.
    https://www.scopus.com/pages/authors/59174404600
  2. ORCID. (n.d.). ORCID record: Mridul Guleria, ORCID iD 0009-0008-5898-8134. ORCID.
    https://orcid.org/0009-0008-5898-8134
  3. World Science Awards. (n.d.). World Science Awards.
    https://worldscienceawards.com/

Mohammad Seyedabadi | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mohammad Seyedabadi, Mazandaran University of Medical Sciences
Mohammad Seyedabadi
Affiliation Mazandaran University of Medical Sciences
Country Iran
Scopus ID 24460920400
Documents 86
Citations 2,110
h-index 25
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-0044-8270

Mohammad Seyedabadi is a researcher affiliated with Mazandaran University of Medical Sciences in Iran, with a documented research specialization in pharmacology. The academic recognition presented in this article is the Best Researcher Award associated with the World Science Awards. The supplied research profile records 86 documents, 2,110 citations, and an h-index of 25. These bibliometric indicators provide a quantitative overview of the documented research record and are presented as profile information rather than as independent measures of scientific quality. Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic effects, adverse effects, and interactions with biological systems. [1][2]

Abstract

This article presents an academic recognition profile for Mohammad SEYEDABADI of Mazandaran University of Medical Sciences, Iran, in connection with the Best Researcher Award under the World Science Awards. The documented research subject is pharmacology, a biomedical discipline concerned with the properties, mechanisms, therapeutic applications, and safety of drugs and other bioactive substances. [1][2] The supplied bibliometric record identifies 86 documents, 2,110 citations, and an h-index of 25. These indicators suggest a substantial indexed research record within the supplied profile, while their interpretation should account for publication history, disciplinary citation practices, collaboration patterns, and the characteristics of individual publications. The award suitability discussion therefore considers the documented research specialization, publication volume, citation activity, and overall bibliometric profile without treating these measures as substitutes for qualitative assessment.

Keywords

  • Pharmacology
  • Drug discovery
  • Pharmacological research
  • Therapeutics
  • Pharmacodynamics
  • Pharmacokinetics
  • Biomedical science
  • Research impact

Introduction

Pharmacology is a central biomedical discipline that examines how chemical substances interact with living systems. It includes the study of drug mechanisms, pharmacodynamics, pharmacokinetics, therapeutic efficacy, adverse effects, and interactions. [1][2] Pharmacological research provides a scientific basis for understanding the actions of medicines and for supporting the development and evaluation of therapeutic interventions.

Modern pharmacology is closely connected with molecular biology, physiology, biochemistry, toxicology, medicinal chemistry, and clinical medicine. Research may range from investigations of molecular targets and signaling pathways to experimental evaluation of candidate compounds and clinical studies of therapeutic responses. The integration of these disciplines has contributed to the development of more selective treatments and improved understanding of drug response variability. [2][3]

Within this scientific context, Mohammad SEYEDABADI is identified in the supplied profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences. The reported record of 86 documents, 2,110 citations, and an h-index of 25 provides a quantitative description of the indexed research profile. Further conclusions regarding specific scientific discoveries or therapeutic applications require examination of the underlying publications and verified research outputs.

Research Profile

Mohammad SEYEDABADI is affiliated with Mazandaran University of Medical Sciences in Iran. The supplied subject classification is pharmacology, placing the profile within the broader biomedical and pharmaceutical sciences. The reported combination of publication output and citation activity provides a bibliometric overview of the researcher’s indexed scholarly record. An h-index of 25 indicates that, within the supplied record, at least 25 publications have received at least 25 citations each, subject to the accuracy and coverage of the underlying database record. Bibliometric indicators should nevertheless be interpreted in their disciplinary and temporal context.

Research Contributions

The documented specialization of Mohammad SEYEDABADI is pharmacology. As a broad research field, pharmacology contributes to the scientific understanding of how therapeutic agents interact with biological targets and how those interactions influence physiological and pathological processes. [1][2] Pharmacological investigations may address molecular mechanisms, drug efficacy, safety, metabolism, therapeutic response, and interactions between medicines.

The supplied profile does not identify specific publication titles, experimental models, molecular targets, compounds, therapeutic areas, or clinical outcomes. Therefore, specific technical contributions are not attributed to the researcher beyond the documented subject classification. A detailed assessment of individual contributions would require review of the researcher’s publications and associated bibliographic records.

  • Research activity within the field of pharmacology.
  • Contribution to the indexed biomedical literature through a reported record of 86 documents.
  • Documented citation activity of 2,110 citations within the supplied profile.
  • A reported h-index of 25 as a measure of citation distribution within the indexed record.

These indicators describe scholarly output and visibility but do not by themselves establish the novelty, methodological quality, clinical relevance, or translational significance of individual studies.

Publications

The supplied research profile reports 86 documents and 2,110 citations. It does not provide a complete publication list, individual publication titles, journal information, publication dates, authorship details, or DOI identifiers for the researcher’s works. Consequently, no specific publication metadata are inferred in this article. For authoritative publication-level information, the researcher’s Scopus author record should be consulted directly. Database coverage, author disambiguation, citation counts, and document totals may change as indexing systems are updated.

Research Impact

The supplied profile reports 2,110 citations across 86 documents and an h-index of 25. These figures indicate that the indexed research record has received substantial citation activity within the reported database profile. Citation counts can provide evidence of scholarly visibility, although they do not by themselves measure research quality, reproducibility, clinical importance, or societal impact.

In pharmacology, research impact may arise through advances in understanding drug mechanisms, identification of biological targets, evaluation of therapeutic efficacy, characterization of safety profiles, or contributions to translational and clinical research. [1][2][3] The significance of a particular contribution therefore depends on the scientific question addressed, methodological rigor, reproducibility, and subsequent use of the findings.

For this profile, the available evidence supports a quantitative description of research impact based on document and citation counts and the reported h-index. Determining broader scientific or clinical impact would require additional evidence, such as highly cited publications, clinical translation, patents, guidelines, collaborations, or documented changes in research or healthcare practice.

Award Suitability

The Best Researcher Award profile is thematically aligned with Mohammad SEYEDABADI’s documented research specialization in pharmacology and the supplied record of scholarly output. The profile reports 86 documents, 2,110 citations, and an h-index of 25, providing several quantitative indicators that may be relevant when evaluating research activity and scholarly visibility.

The researcher is affiliated with Mazandaran University of Medical Sciences and is identified through Scopus Author ID 24460920400 and ORCID 0000-0003-0044-8270. These persistent identifiers provide mechanisms for distinguishing the researcher’s scholarly record and supporting bibliographic verification. On the basis of the supplied information, the profile provides a clear research-area match and a documented scholarly record that can support consideration for an award recognizing research activity. A formal award decision should additionally consider the official eligibility requirements, originality of research, methodological quality, peer-reviewed contributions, field-specific significance, and any qualitative criteria established by the World Science Awards.

Conclusion

Mohammad SEYEDABADI is identified in the supplied academic profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences in Iran. The reported research record includes 86 documents, 2,110 citations, and an h-index of 25. These indicators provide a quantitative representation of the researcher’s indexed scholarly activity and citation visibility.

Pharmacology is an established biomedical field with direct relevance to drug mechanisms, therapeutic development, safety assessment, and clinical science. [1][2] The documented research specialization and bibliometric record provide a reasonable academic basis for an award profile focused on research achievement, while a comprehensive assessment of scientific distinction should incorporate publication-level evidence and qualitative evaluation in accordance with the applicable award criteria.

References

  1. Katzung, B. G., Vanderah, T. W. Basic & Clinical Pharmacology. McGraw Hill. This reference provides a general foundation for pharmacodynamics, pharmacokinetics, drug mechanisms, and therapeutic pharmacology.
  2. Brunton, L. L., Hilal-Dandan, R., Knollmann, B. C., eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw Hill. The text provides established principles concerning drug actions, therapeutic effects, mechanisms, and adverse reactions.
  3. Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., Henderson, G. Rang & Dale’s Pharmacology. Elsevier. This reference covers pharmacological mechanisms and the relationship between drugs and biological systems.
  4. Scopus. Scopus Author Profile: Mohammad SEYEDABADI, Author ID 24460920400. The supplied profile identifies the researcher and reports the bibliometric information used in this article.
  5. ORCID. ORCID Record: Mohammad SEYEDABADI, ORCID 0000-0003-0044-8270. The persistent identifier is supplied as the researcher’s ORCID record.

The DOI references above are provided where applicable to support established scholarly literature. The researcher-specific bibliometric values in this article are based on the supplied profile information and should be checked against the current database records for the latest values.

Carolina Batista | Pharmaceutical Science | Women Researcher Award

Published on by World Science Awards

Dr. Carolina Batista | Pharmaceutical Science | Women Researcher Award

Biomedical from Federal University of Rio de Janeiro, Brazil

Dr. Carolina Batista is a distinguished global health physician with over two decades of experience in humanitarian and public health initiatives. Currently serving as the Head of Global Health Affairs at Baraka Impact Finance, she leverages her medical expertise and strategic insight to foster innovative health solutions for underserved populations. Her career commenced in Brazil, where she provided medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia, Africa, and Latin America, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. As Director of MSF’s Brazilian Medical Unit, she led international campaigns, notably for Chagas disease. Subsequently, at the Drugs for Neglected Diseases initiative (DNDi), she spearheaded access frameworks for NTDs across Latin America, influencing public policies and fostering partnerships. Dr. Batista holds a medical degree from Brazil and a master’s in International Public Health from institutions including the Swiss Tropical and Public Health Institute. Her contributions extend to roles on the International Board of MSF, The Lancet COVID-19 Commission, and as a strategic advisor for ISGlobal, reflecting her commitment to health equity and innovation in global health.

Professional Profile

Education

Dr. Carolina Batista’s educational journey is marked by a blend of clinical training and global public health expertise. She earned her medical degree in Brazil, grounding her in clinical practice and primary healthcare delivery. Pursuing a broader impact, she obtained a master’s degree in International Public Health through a collaborative program involving the Swiss Tropical and Public Health Institute, the Institute of Tropical Medicine in Antwerp, and the Royal Tropical Institute in Amsterdam. This multidisciplinary education equipped her with a comprehensive understanding of global health challenges, particularly in infectious and neglected diseases. Further enhancing her capabilities, Dr. Batista pursued advanced studies in management, health and human rights, and policy and advocacy from renowned institutions. This diverse educational background has been instrumental in her ability to design and implement effective health interventions and policies across various international contexts.

Professional Experience

Dr. Carolina Batista’s professional trajectory encompasses significant roles in global health organizations. Her career began in Brazil, providing medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia and later serving as Director of the Brazilian Medical Unit, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. She led international campaigns, notably for Chagas disease, and coordinated MSF’s medical response to COVID-19 in the Navajo Nation, USA. At the Drugs for Neglected Diseases initiative (DNDi), she served as Head of Access and Medical Affairs, developing access frameworks for NTDs across Latin America. Currently, as Head of Global Health Affairs at Baraka Impact Finance, she supports social entrepreneurs in developing innovative health solutions. Dr. Batista also holds positions on the International Board of MSF and serves as a strategic advisor for ISGlobal

Research Interests

Dr. Carolina Batista’s research interests are deeply rooted in global health equity, focusing on neglected tropical diseases (NTDs), health systems in low- and middle-income countries, and access to healthcare for vulnerable populations. She is particularly interested in the development and implementation of innovative financing mechanisms to achieve the Sustainable Development Goals (SDGs), the role of private capital in bridging healthcare access gaps, and the integration of ethical artificial intelligence in health communication. Her work also explores the intersection of migration and health, pandemic preparedness, and the gender gap in healthcare access. Dr. Batista’s research aims to inform policies and practices that enhance healthcare delivery and accessibility for marginalized communities worldwide.

Research Skills

Dr. Carolina Batista possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. Her expertise includes treatment protocols, health systems analysis, diagnostics, and primary care, particularly concerning parasitic and neglected diseases. She is adept at designing and implementing operational research projects, developing access frameworks, and conducting policy analysis. Her skills extend to evaluating health programs, engaging with stakeholders, and advocating for policy changes. Dr. Batista’s proficiency in these areas enables her to contribute effectively to research initiatives aimed at improving health outcomes in underserved populations.

Awards and Honors

Dr. Carolina Batista’s contributions to global health have been recognized through various appointments and memberships. She serves on the International Board of Médecins Sans Frontières (MSF) and is a strategic advisor for the Barcelona Institute for Global Health (ISGlobal). Her role in leading MSF’s medical response to COVID-19 in the Navajo Nation and her involvement in The Lancet COVID-19 Commission underscore her commitment to addressing health crises. Additionally, she chairs the DNDi Latin America board and serves on the boards of The Lancet Migration Latin America, Movement Health Foundation, and Health in Harmony. These positions reflect her leadership and dedication to advancing health equity and innovation.

Conclusion

Dr. Carolina Batista exemplifies a career dedicated to advancing global health equity through clinical practice, research, and policy development. Her extensive experience with organizations like MSF and DNDi, coupled with her strategic role at Baraka Impact Finance, highlights her commitment to improving healthcare access for marginalized populations. Her educational background and research interests inform her holistic approach to health challenges, integrating innovative solutions with traditional practices. Dr. Batista’s leadership roles and board memberships further demonstrate her influence in shaping global health policies and initiatives. Her work continues to inspire and drive progress towards equitable healthcare worldwide.

Publications Top Notes

1. Exposed Subsoil Under Recovery for 30 Years: Influence of Management Strategies on Soil Physical Attributes and Organic Matter

  • Authors: Laura Silva Nantes, Carolina dos Santos Batista Bonini, Melissa Alexandre Santos, Lucas da Silva Alves, Josiane Lourencetti, Alfredo Bonini Neto, José Augusto Liberato de Souza, Gabriel Augusto da Silva Lunardelli, Mariana Bonini Silva, Dayara Vivian Alvares, et al.

  • Year: 2025

2. Accumulated Carbon Fractions in Tropical Sandy Soils and Their Effects on Fertility and Grain Yield in an Integrated Crop–Livestock System

  • Authors: Deyvison de Asevedo Soares, Bianca Midori Souza Sekiya, Viviane Cristina Modesto, Allan Hisashi Nakao, Leandro Alves Freitas, Isabela Malaquias Dalto de Souza, J.H.S. Luz, Fernando Shintate Galindo, Gelci Carlos Lupatini, Gustavo Pavan Mateus, et al.

  • Year: 2023

3. Evolution of Soil Chemical Fertility in an Area under Recovery for 30 Years with Anthropic Intervention

  • Authors: Josiane Lourencetti, Carolina dos Santos Batista Bonini, Marcelo Andreotti, Marlene Cristina Alves, Alfredo Bonini Neto, Melissa Alexandre Santos, Vitor Correa de Mattos Barretto, Roberth Wicleff Rodrigues de Figueredo

  • Year: 2023

4. Long-Term Integrated Systems of Green Manure and Pasture Significantly Recover the Macrofauna of Degraded Soil in the Brazilian Savannah

  • Authors: Carolina dos Santos Batista Bonini, Thais Monique de Souza Maciel, Bruno Rafael de Almeida Moreira, José Guilherme Marques Chitero, Rodney Lúcio Pinheiro Henrique, Marlene Cristina Alves

  • Year: 2023

5. Long-Term Integrated Crop–Livestock–Forestry Systems Recover the Structural Quality of Ultisol Soil

  • Authors: Aline Matos, Carolina dos Santos Batista Bonini, Bruno Rafael de Almeida Moreira, Marcelo Andreotti, Reges Heinrichs, Diogo Tiago da Silva, José Augusto Liberato de Souza, Melissa Alexandre Santos, Cristiana Andrighetto, Gustavo Mateus Pavan, et al.

  • Year: 2022

6. Azospirillum Inoculation of ‘Marandu’ Palisade Grass Seeds: Effects on Forage Production and Nutritional Status

  • Authors: Reges Heinrichs, G.C. Meirelles, L.F. de Melo Santos, M.V. da Silva Lira, A. de Marcos Lapaz, M.A. Nogueira, C. dos Santos Batista Bonini, Filho, A. Moreira

  • Year: 2020

7. Can Palisade and Guinea Grass Sowing Time in Intercropping Systems Affect Soybean Yield and Soil Chemical Properties?

  • Authors: N.R. Costa, Marcelo Andreotti, C.A.C. Crusciol, C.M. Pariz, J.W. Bossolani, A.M.D. Castilhos, C.A.C.D. Nascimento, C.G.D.R. Lima, C. dos Santos Batista Bonini, E.E. Kuramae

  • Year: 2020

8. Effect of Sulfur Sources on Megathyrsus Maximus ‘Mombaça’ Grass Cultivated in a Typic Ultisol

  • Authors: L.F. de Melo Santos, A. de Marcos Lapaz, F.V. Ribeiro, I.V. Ribeiro, G.C. Meirelles, M.V. da Silva Lira, C.V. Soares Filho, C. dos Santos Batista Bonini, A.R. dos Reis, A. Moreira, et al.

  • Year: 2020

9. Soil Compaction in Crop-Livestock-Forest Integration Systems of Five Years of Implantation and Use

  • Authors: J.F.D. Souza, C. dos Santos Batista Bonini, G.P. Mateus, C.T. de Souza, R.L.S. Perusso, F.G. Pedro, G.L. Oliverio

  • Year: 2020

10. Spray Nozzles and Droplet Size Effects on Soybean Canopy Deposits and Stink Bugs Control in West Region of São Paulo State – Brazil

  • Authors: M.A.G.L. Farias, C.G. Raetano, R.G. Chechetto, P.J. Ferreira-Filho, J.C. Guerreiro, C.S.B. Bonini, A.C. Firmino, R.C. Lima, E.P. Prado

  • Year: 2020

​






	


	

	






	
	

		


Serkan Yigitkan | Pharmaceutical Science | Best Researcher Award
			

				Published on  by World Science Awards			

		
	


	

		
Assist. Prof. Dr. Serkan Yigitkan | Pharmaceutical Science | Best Researcher Award


Dicle University, Turkey


Dr. Serkan Yiğitkan is a distinguished pharmacognosist affiliated with Dicle University’s Institute of Health Sciences in Diyarbakır, Turkey. His academic journey is marked by a profound dedication to the study of medicinal plants and their applications in healthcare. With a robust portfolio of 18 publications and a significant number of citations, Dr. Yiğitkan has established himself as a leading figure in his field. His research primarily focuses on the pharmacological properties of natural products, aiming to bridge the gap between traditional herbal remedies and modern medicine. Through his work, he seeks to validate and harness the therapeutic potentials of phytochemicals, contributing to the development of novel treatments for various ailments.


Professional Profile



Education


Dr. Yiğitkan completed his doctoral studies in pharmacognosy at Dicle University, where he delved into the chemical and biological properties of medicinal plants. His education provided a solid foundation in understanding the complexities of plant-based compounds and their interactions within biological systems. This academic background has been instrumental in shaping his research trajectory, allowing him to explore the vast potential of phytochemicals in therapeutic applications. His commitment to continuous learning and research is evident in his contributions to the scientific community, particularly in the realm of natural product pharmacology.


Professional Experience


Throughout his career, Dr. Yiğitkan has been actively involved in various research projects and academic collaborations. His role at Dicle University encompasses both teaching and research, where he mentors students and leads studies on the pharmacological effects of medicinal plants. His professional journey is characterized by a dedication to advancing the understanding of natural products and their potential therapeutic benefits. Through his involvement in numerous studies and publications, he has contributed significantly to the field of pharmacognosy, particularly in exploring the antimicrobial and antioxidant properties of plant extracts.


Research Interests


Dr. Yiğitkan’s research interests are centered around the pharmacological evaluation of medicinal plants, with a particular focus on their antimicrobial and antioxidant properties. He is keenly interested in identifying bioactive compounds that can serve as potential therapeutic agents. His work often involves the extraction and characterization of phytochemicals, aiming to discover novel compounds with significant health benefits. By investigating the traditional uses of plants and validating their efficacy through scientific methods, he contributes to the integration of herbal medicine into modern therapeutic practices.


Research Skills


Dr. Yiğitkan possesses a diverse set of research skills, including expertise in chromatographic techniques, bioassay-guided fractionation, and the evaluation of biological activities of natural products. His proficiency in these methodologies enables him to isolate and identify active compounds from complex plant matrices effectively. Additionally, his skills in designing and conducting experiments related to antimicrobial and antioxidant assays have been pivotal in advancing his research objectives. His methodological approach ensures the reliability and reproducibility of his findings, contributing to the broader scientific understanding of medicinal plants.


Awards and Honors


While specific awards and honors are not detailed in the available information, Dr. Yiğitkan’s contributions to the field of pharmacognosy are evident through his extensive publication record and the impact of his research. His work has garnered attention within the scientific community, reflecting his commitment to advancing knowledge in natural product research. The recognition of his studies by peers and the inclusion of his research in reputable journals underscore his standing as a respected scientist in his field.


Conclusion


Dr. Serkan Yiğitkan’s dedication to exploring the medicinal properties of plants has significantly enriched the field of pharmacognosy. His research endeavors have not only advanced scientific understanding but also paved the way for the development of novel therapeutic agents derived from natural sources. Through his meticulous studies and commitment to integrating traditional knowledge with modern science, Dr. Yiğitkan exemplifies the vital role of researchers in bridging cultural heritage and contemporary medicine. His ongoing efforts continue to inspire and contribute to the global appreciation of plant-based therapeutics.


Publications Top Notes


    

  1. 

    Title: Assessment of the Anti-Acne Properties of Some Medicinal Plants and Development of an Herbal Anti-Acne Formulation
    Authors: F. Sezer Senol Deniz, Ozlem Oyardı, Cagla Bozkurt Guzel, Tahir Emre Yalcın, Serkan Yiğitkan, Yuksel Kan, Nurver Ulger Toprak, Ilkay Erdogan Orhan
    Year: 2025
    

    2. 

  2. 

    Title: LC-MS/MS Analysis and Biological Activities of Different Parts of Ziziphora capitate L.
    Authors: Serkan Yiğitkan, Mehmet Çavuşoğlu, Mehmet Veysi Çağlayan, İsmail Yener, Mehmet Fırat, Eda Çavuş Kaya, Mustafa Abdullah Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    3. 

  3. 

    Title: Ziziphora clinopodioides Lam. Türünün Kültür İle Doğal Ortamlarda Yetişen Örneklerinin Kimyasal ve Biyolojik Yönden Detaylı İncelenmesi
    Authors: Mehmet Çavuşoğlu, Serkan Yiğitkan, İsmail Yener, Mehmet Veysi Çağlayan, Barış Reşitoğlu, Mehmet Akdeniz, Eda Çavuş Kaya, Fethullah Tekin, Mustafa Abdullah Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    4. 

  4. 

    Title: A Comprehensive Study on Chemical and Biological Investigation of Thymus Brachychilus Jalas: A Rich Source of Ursolic and Oleanolic Acids
    Authors: Mehmet Akdeniz, Serkan Yiğitkan, Mustafa Abdullah Yılmaz, İsmail Yener, Elif Varhan Oral, Mehmet Fırat, Ilkay Erdogan Orhan, Ufuk Kolak, Abdulselam Ertaş
    Year: 2024
    

    5. 

  5. 

    Title: Essential Oil Contents and Biological Activities of Thymus Canoviridis Jalas and Thymus Sipyleus Boiss.
    Authors: Serkan Yiğitkan, Mehmet Fırat
    Year: 2024
    

    6. 

  6. 

    Title: An Investigation of the ACE Inhibitory Activity, Antioxidant Capacity, and Phytochemical Constituents of Polar and Non-Polar Extracts of Ziziphus Jujuba Fruit: Statistical Screening of the Main Components Responsible for Bioactivity
    Authors: Bahar Fındık, Hilal Yıldız, Esma Birişçi, Serkan Yiğitkan, Pelin Köseoğlu Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    7. 

  7. 

    Title: Comprehensive Study of Chemical Composition and Biological Activity of Thymus pubescens Boiss. et Kotschy ex Čelak.
    Authors: Serkan Yiğitkan, Mehmet Akdeniz, İsmail Yener, Zeki Seker, Mustafa Abdullah Yılmaz, Mehmet Fırat, Deniz Evrim Kavak, Pelin Yılmaz Köseoğlu, Abdulselam Ertaş, Ufuk Kolak
    Year: 2022
    

    8.